News
UK Free Trade Agreement is set to boost pharmaceutical and medical device exports by providing procedural flexibility, ...
The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...
India-UK free trade agreement eliminates tariffs on generic drugs and medical devices, boosting Indian exports to the UK market. This opens significant growth opportunities for Indian pharmaceutical ...
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...
4h
Zacks Investment Research on MSNWest Pharmaceutical Services (WST) Surpasses Q2 Earnings and Revenue Estimates
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.52 per share a year ago ...
We primarily deployed the proceeds from selling Nilorn into Havas in the first quarter and into Fortrea during the second ...
Select specialty chemical firms are quietly powering India’s EV revolution. Discover how these behind-the-scenes players are ...
17h
Zacks Investment Research on MSNRecursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note
In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.68% at $6.43. This change lagged the S&P 500's 0.78% gain on the day. Elsewhere, the Dow gained 1.14%, while the tech-heavy ...
Analysts are positive on the Malaysian healthcare sector, driven by its resilient long-term structural growth drivers, ...
3don MSN
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, especially for those who opt to reinvest the dividend.
4h
ABP - Live on MSNIndia-UK FTA: Which Sectors Will Win Big In The UK Market? Details Inside
This FTA between India and the UK is poised to transform India's export landscape by offering zero-duty market access and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results